Results of the Treatment of Cystic Hygroma with Intralesional Bleomycin Injection: A Preliminary Report in 20 Pediatric Patients

Authors

  • Rangsan Niramis Department of Surgery, Queen Sirikit National Institute of Child Health (Children's Hospital), Bangkok, Thailand.
  • Sukawat Watanatittan Department of Surgery, Queen Sirikit National Institute of Child Health (Children's Hospital), Bangkok, Thailand.

Abstract

Introduction: Cystic hygroma is a malformation of lymphatic vessels. Surgical excision is the treatment of choice but it has a high risk of recurrence and injury to the major organs. Bleomycin injection into the cysts can be used in cases of large cystic masses in order to avoid nerve injury and scar formation.

Method: A prospective study was performed during the period of 1 992- 1 998. Twenty pediatric patients with cystic bygroma wexe treated with intralesional bleomycin injection. Fifteen were male and 5 were female. Their age ranged from I month to ll years. Ten patients had recurrence of the disease post surgical excision before this man agement. The site of cystic hygroma was predominantly in the neck. The size of these lesions was larger than 5 cm in diameter in every case. After aspiration of the cyst contents, 3-10 mg of bleomycin was administered into the cavities. Repeated injections were performed at an interval of 2 to 6 weeks in some cases.

Results: An excellent response (complete clinical resolution) was obtained in 9 cases (45%). A good response (partial reduction of the size of the masses) was achieved in 7 patients (35% ). A poor result (no clinical improvement) was noted in 4 cases (20% ). Adverse reactions including fever, local swelling, redness and pain at the site of injection were found in 12 patients (60%) and they were present only for a few days. Leucopenia was noted in 3 infants below one year of age (15% ).

Conclusion: Our data from this study suggested that intralesional bleomycin injection was an effective therapy in some cases of cystic hygroma. It should be used in the patients with large cystic masses, in which a surgical excision might be incomplete and risk of vital organ injuries may be high.

References

1. Landing BH, Farber S. Tumors of the cardiovascular system. Atlas of Tumor Pathology, vol 7. Washington DC : United States Armed Force Institute of Pathology , 1 956: 124-35.

2. Stal s, Hamilton S, Spira M, Hemangiomas, lymphangiomas and vascular malformation of the head and neck. Otolaryngol Clin North Am 1986; 19:769-797 .

3. Bill AH, Sumner DS. A unified concept of lymphangioma and cystic hygroma. Surg Gynecol Obstet 1965; 120:79-86.

4. Ninh TN, Ninh TA. Cystic hygroma : a report of 126 cases. J Pediatr Surg 1974; 9:191-5.

5. Singh S, Baboo ML, Pathak IC, Cystic lymphangioma in children : report of 33 cases including lesions of rare sites. Surgery 1971; 69:947-51.

6. Chait D, Yonker AJ, Beddoe GM, et al. Management of cystic hygromas. Surg Gynecol Obstet 1974;139:55-8.

7. Watanatittan S, Cystic hygroma, In : Havanondas, Sutthiwan P, Thitawat W, et al, eds. Progress in Surgery Series of the Royal College of Surgeons of Thailand, vol 3,1983:209-12 (in Thai).

8. Harrower G. Treatment of cystic hygroma of the neck by sodium morrhuate. Br Med J 1933: 2:148-55.

9. Goldberg MH, Nemarich AN, Danielson P. Lymphangioma of the tongue : medical and surgical therapy. J Oral Surg 1977;35:841-7.

10. Wilfinger P, Martin R, Papp C. Magnesium seeds in the treatment of lymp-and haemangiomata. Chir Plast 1981;6:105.

11. Yura J, Hashimoto T, Tsuruga N, et al. Bleomycin treatment for cystic hygroma in children. Arch Jpn Chir 1977; 46:607-12.

12. Tanigawa N,Shimomatsuya T, Takahashi K, et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin in fat emulsion. Cancer 1987; 60:741 -9.

13. Okada A. Kubota A. Fukuzawa M, et al, I njection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg 1992; 27:440-3.

14. Ojino N, Okada A, Nakamura T, et al. Treatment of cystic lymphangioma with topical use of bleomycin. Jpn J Pediatr Surg 1984; 16:925-30.

15. Tanaka K,Inomata Y, Utsunomiya H, et al. Sclerosing therapy with bleomycin emulsion for lymphangioma in children. Pediatr Surg Int 1990; 5:270-3.

16.Orford J, Barker A, Thonel S, et al. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995; 30:1282-7.

17. Umezawa H. Recent studies on biochemistry and action on bleomycin. In : Carter SK, Crooke ST, Umezawa H, eds. Bleomycin Current Status and New Developments. New York : Academic Press, 1978: 15-20.

18. Calabresi P, Chabner BA. Chemotherapy of neoplastic disease : bleomycin. In : Hardman JG, Limbird LE, Molinoff PW, et al,eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York : Mc Graw-Hill,1996: 1266-8.

Downloads

Published

1999-03-31

How to Cite

1.
Niramis R, Watanatittan S. Results of the Treatment of Cystic Hygroma with Intralesional Bleomycin Injection: A Preliminary Report in 20 Pediatric Patients. Thai J Surg [Internet]. 1999 Mar. 31 [cited 2024 Mar. 28];20(1):9-14. Available from: https://he02.tci-thaijo.org/index.php/ThaiJSurg/article/view/247798

Issue

Section

Original Articles